News

The objective of this study was to evaluate the compound's preliminary safety and tolerability by treating six separate groups of healthy volunteers. In addition to safety and tolerability,

The phase I trial is a dose-escalation study that will enroll patients with relapsed or refractory acute myeloid leukemia (AML). AC220 will be administered daily via oral solution,

The first litigation suit concerned the Iridex proprietary laser probe connector technology. The second suit involved the Synergetics directional laser probe technology and the Iridex patent pending application

EpiCept is testing its NP-1 drug for use in two different indications and believes it has the largest market potential of any of its pain product candidates. EpiCept

As part of the merger agreement Inhibitex will gain two antiviral development programs to enhance its anti-infective drug development capabilities, including FV-100, for the treatment of shingles and

GSK and Adolor have suspended two studies investigating Entereg, until further analysis of the data has been completed. The FDA had requested an additional safety study for Entereg

Soft tissue sarcoma includes cancers of cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. “The treatment of advanced, soft tissue sarcoma remains a major unmet

Patients who undergo hepatitis B-related liver transplantation require long-term post-transplant therapy with hepatitis B immune globulin. Clinical trial data showed HepaGam B was highly effective at preventing hepatitis

The proposal was delivered to medical diagnostics company Biosite on April 4th. Biosite has already agreed to a merger buyout with Beckman Coulter, a California company that designs,